Clinical Trials in Illinois

Showing 17501-17520 of 19,692 trials

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

NCT00594425

This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.The results from part 2 has been presented in the result section.

Acne Vulgaris

Photocure150 participantsStarted Feb 2007

San Diego, California, United States • Vallejo, California, United States • Naperville, Illinois, United States +11 more locations

COMPLETEDPhase 2116 miles

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

NCT00583830

The purpose of this study is to evaluate the efficacy (disease response) and safety of mapatumumab in combination with carboplatin and paclitaxel as first line therapy in subjects with advanced non-small cell lung cancer (NSCLC).

Non Small Cell Lung Cancer

Human Genome Sciences Inc.111 participantsStarted Jan 2007

Birmingham, Alabama, United States • Rancho Mirage, California, United States • Aurora, Colorado, United States +30 more locations

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer

Find Trials by Condition in Illinois

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome

Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Optimizing Electroconvulsive Therapy for Depression

Novartis H1N1 Vaccine in Pregnant Women

Case-Control Viramune (Nevirapine) Toxicogenomics Study

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Toe Walker Gait Trial

Dynamic Splinting for Patients With Adhesive Capsulitis

Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer